VisionGate is Leveraging the Cell-CT™ Platform to Expand Cancer Diagnostics Services
SEATTLE, WA (April 5, 2018) – VisionGate, a clinical stage oncology pharmaceutical and diagnosticscompany, is pleased to announce today the advancement of its breakthrough technology Cell-CT platform. The first shipment of commercial-capable Cell-CT systems [...]